Participants with SCD with low ApoA1 levels (<115 mg/dL) had higher levels of laboratory markers of hemolysis (bilirubin, LDH, and Hb) and inflammation (white blood cells). This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.